These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36884131)

  • 1. Threat of respiratory syncytial virus infection knocking the door: a proposed potential drug candidate through molecular dynamics simulations, a future alternative.
    Mitra D; Afreen S; Das Mohapatra PK; Abdalla M
    J Mol Model; 2023 Mar; 29(4):91. PubMed ID: 36884131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of respiratory syncytial virus infections: the final breakthrough.
    De Clercq E
    Int J Antimicrob Agents; 2015 Mar; 45(3):234-7. PubMed ID: 25684638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database.
    Law BJ; Wang EE; MacDonald N; McDonald J; Dobson S; Boucher F; Langley J; Robinson J; Mitchell I; Stephens D
    Pediatrics; 1997 Mar; 99(3):E7. PubMed ID: 9099772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy for respiratory tract infections caused by respiratory syncytial virus.
    van Woensel J; Kimpen J
    Eur J Pediatr; 2000 Jun; 159(6):391-8. PubMed ID: 10867842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WITHDRAWN: Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children.
    Ventre K; Randolph A
    Cochrane Database Syst Rev; 2010 May; 2010(5):CD000181. PubMed ID: 20464715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children.
    Ventre K; Randolph A
    Cochrane Database Syst Rev; 2004 Oct; (4):CD000181. PubMed ID: 15494991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children.
    Ventre K; Randolph AG
    Cochrane Database Syst Rev; 2007 Jan; (1):CD000181. PubMed ID: 17253446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.
    Wendt CH; Hertz MI
    Semin Respir Infect; 1995 Dec; 10(4):224-31. PubMed ID: 8668850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-to-date role of biologics in the management of respiratory syncytial virus.
    Boyoglu-Barnum S; Tripp RA
    Expert Opin Biol Ther; 2020 Sep; 20(9):1073-1082. PubMed ID: 32264720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection.
    Pelaez A; Lyon GM; Force SD; Ramirez AM; Neujahr DC; Foster M; Naik PM; Gal AA; Mitchell PO; Lawrence EC
    J Heart Lung Transplant; 2009 Jan; 28(1):67-71. PubMed ID: 19134533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory syncytial virus disease: update on treatment and prevention.
    Krilov LR
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):27-32. PubMed ID: 21171875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients.
    Hynicka LM; Ensor CR
    Ann Pharmacother; 2012 Apr; 46(4):558-66. PubMed ID: 22395247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.
    Akhmedov M; Wais V; Sala E; Neagoie A; Nguyen TM; Gantner A; von Harsdorf S; Kuchenbauer F; Schubert A; Michel D; Döhner H; Bunjes D
    Transpl Infect Dis; 2020 Aug; 22(4):e13276. PubMed ID: 32162389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus infection in adults.
    Falsey AR
    Semin Respir Crit Care Med; 2007 Apr; 28(2):171-81. PubMed ID: 17458771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
    Glanville AR; Scott AI; Morton JM; Aboyoun CL; Plit ML; Carter IW; Malouf MA
    J Heart Lung Transplant; 2005 Dec; 24(12):2114-9. PubMed ID: 16364859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group.
    Moler FW; Steinhart CM; Ohmit SE; Stidham GL
    J Pediatr; 1996 Mar; 128(3):422-8. PubMed ID: 8774517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients.
    Foolad F; Aitken SL; Shigle TL; Prayag A; Ghantoji S; Ariza-Heredia E; Chemaly RF
    Clin Infect Dis; 2019 May; 68(10):1641-1649. PubMed ID: 30202920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection.
    Azzi JM; Kyvernitakis A; Shah DP; El Haddad L; Mahajan SN; Ghantoji SS; Heredia-Ariza E; Chemaly RF
    J Antimicrob Chemother; 2018 Nov; 73(11):3162-3169. PubMed ID: 30113677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and treatment recommendations for respiratory syncytial virus infection. Background and clinical experience 40 years after discovery.
    Ottolini MG; Hemming VG
    Drugs; 1997 Dec; 54(6):867-84. PubMed ID: 9421694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.